Characterization of TNF-induced cell death in Drosophila reveals caspase- and JNK-dependent necrosis and its role in tumor suppression.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
14 08 2019
Historique:
received: 15 04 2019
accepted: 01 08 2019
revised: 31 07 2019
entrez: 15 8 2019
pubmed: 15 8 2019
medline: 31 7 2020
Statut: epublish

Résumé

Tumor-necrosis factor (TNF) and its superfamily members are pleiotropic cytokines. Activation of TNF can lead to distinct cellular outcomes including inflammation, cell survival, and different forms of cell death, such as apoptosis and necrosis in a context-dependent manner. However, our understanding of what determines the versatile functions of TNF is far from complete. Here, we examined the molecular mechanisms that distinguish the forms of cell death induced by Eiger (Egr), the sole homolog of TNF in Drosophila. We show that expression of Egr in the developing Drosophila eye simultaneously induces apoptosis and apoptosis-independent developmental defects indicated by cellular disorganization, both of which rely on the c-Jun N-terminal kinase (JNK) signaling activity. Intriguingly, when effector caspases DrICE and Dcp-1 are defective or inhibited, expression of Egr triggers necrosis which is characterized by loss of cell membrane integrity, translucent cytoplasm, and aggregation of cellular organelles. Moreover, such Egr-induced necrosis depends on the catalytic activity of the initiator caspase Dronc and the input from JNK signaling but is independent of their roles in apoptosis. Further mosaic analysis with mutants of scribble (scrib), an evolutionarily conserved tumor suppressor gene regulating cell polarity, suggests that Egr/JNK-mediated apoptosis and necrosis establish a two-layered defense system to inhibit the oncogenic growth of scrib mutant cells. Together, we have identified caspase- and JNK-dependent mechanisms underlying Egr-induced apoptosis versus necrosis and their fail-safe roles in tumor suppression in an intact organism in vivo.

Identifiants

pubmed: 31409797
doi: 10.1038/s41419-019-1862-0
pii: 10.1038/s41419-019-1862-0
pmc: PMC6692325
doi:

Substances chimiques

Drosophila Proteins 0
Membrane Proteins 0
Scrib protein, Drosophila 0
Tumor Necrosis Factor-alpha 0
egr protein, Drosophila 0
JNK Mitogen-Activated Protein Kinases EC 2.7.11.24
Caspases EC 3.4.22.-
Dcp-1 protein, Drosophila EC 3.4.22.-
drICE protein, Drosophila EC 3.4.22.-
dronc protein, Drosophila EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

613

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M010880/1
Pays : United Kingdom

Références

Cell Death Differ. 2010 Jun;17(6):912-21
pubmed: 19960025
Cell Death Dis. 2013 Jul 11;4:e723
pubmed: 23846225
Nature. 2015 Jun 25;522(7557):482-6
pubmed: 25874673
J Biol Chem. 2002 Aug 9;277(32):28372-5
pubmed: 12084706
Genes Dev. 2002 Feb 1;16(3):377-87
pubmed: 11825878
Dev Cell. 2009 Mar;16(3):458-65
pubmed: 19289090
PLoS Genet. 2017 Sep 25;13(9):e1007024
pubmed: 28945745
Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18977-82
pubmed: 22065747
Nat Rev Drug Discov. 2016 May;15(5):348-66
pubmed: 26775689
Cell Death Differ. 2003 Jan;10(1):45-65
pubmed: 12655295
Science. 2000 Jul 7;289(5476):113-6
pubmed: 10884224
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Blood. 2012 Jan 19;119(3):651-65
pubmed: 22053109
Semin Immunol. 2014 Jun;26(3):237-45
pubmed: 24647229
Nat Rev Immunol. 2015 Jun;15(6):362-74
pubmed: 26008591
Development. 2014 Apr;141(7):1453-64
pubmed: 24598157
Trends Cancer. 2017 Apr;3(4):294-301
pubmed: 28451648
Nat Commun. 2017 Sep 19;8(1):603
pubmed: 28928435
Cell. 1995 Dec 29;83(7):1253-62
pubmed: 8548811
Semin Immunol. 2014 Jun;26(3):267-74
pubmed: 24981286
Cell Mol Life Sci. 2014 Jan;71(2):331-48
pubmed: 23760205
EMBO J. 2002 Jun 17;21(12):3009-18
pubmed: 12065414
Cell. 2011 Nov 11;147(4):742-58
pubmed: 22078876
PLoS One. 2009 Nov 03;4(11):e7709
pubmed: 19888449
EMBO J. 2006 Nov 15;25(22):5294-304
pubmed: 17082773
Curr Biol. 2016 Mar 7;26(5):575-84
pubmed: 26898463
Development. 1994 Aug;120(8):2121-9
pubmed: 7925015
Development. 2005 Sep;132(17):3935-46
pubmed: 16079158
Genetics. 2003 Dec;165(4):1881-8
pubmed: 14704173
Cell Metab. 2016 Apr 12;23(4):675-84
pubmed: 27076079
Curr Biol. 2002 Jul 23;12(14):1263-8
pubmed: 12176339
Oncogene. 2006 Oct 30;25(51):6758-80
pubmed: 17072327
Dev Cell. 2013 Apr 15;25(1):29-42
pubmed: 23523076
Genes Dev. 1995 Jul 15;9(14):1694-708
pubmed: 7622034
Cell. 2009 Jun 12;137(6):1100-11
pubmed: 19524512
Genes Dev. 1999 Oct 1;13(19):2514-26
pubmed: 10521396
Dev Biol. 1989 Dec;136(2):346-62
pubmed: 2511048
Cell. 2008 May 16;133(4):693-703
pubmed: 18485876
PLoS Genet. 2008 Aug 08;4(8):e1000153
pubmed: 18688282
Science. 2014 Sep 19;345(6203):1250256
pubmed: 25237106
Essays Biochem. 2012;53:141-68
pubmed: 22928514
Apoptosis. 2009 Aug;14(8):1021-8
pubmed: 19466550
EMBO J. 2003 Nov 3;22(21):5769-79
pubmed: 14592975
Dev Cell. 2014 Jul 14;30(1):48-60
pubmed: 24981611
J Biol Chem. 2000 Sep 1;275(35):27084-93
pubmed: 10825159
Cell Signal. 2007 Oct;19(10):2056-67
pubmed: 17644308
Elife. 2016 Mar 14;5:
pubmed: 26974344
Nat Rev Rheumatol. 2016 Jan;12(1):49-62
pubmed: 26656660
Cell Death Differ. 2007 Jan;14(1):32-43
pubmed: 17082813
Methods. 2014 Jun 15;68(1):89-96
pubmed: 24613678
Development. 2006 Sep;133(17):3305-15
pubmed: 16887831
Cell Res. 2012 Feb;22(2):425-31
pubmed: 21844890
Development. 2002 Mar;129(6):1467-76
pubmed: 11880355
EMBO J. 2000 Feb 15;19(4):598-611
pubmed: 10675329
Biochim Biophys Acta. 2011 Apr;1813(4):558-63
pubmed: 21295084
Cell. 2009 Jun 12;137(6):1112-23
pubmed: 19524513
Cytokine Growth Factor Rev. 2014 Aug;25(4):453-72
pubmed: 25169849
Dev Cell. 2004 Dec;7(6):897-907
pubmed: 15572131
J Cell Biol. 2004 Dec 20;167(6):1137-46
pubmed: 15611336
Essays Biochem. 2012;53:129-40
pubmed: 22928513
Science. 2009 Jul 17;325(5938):332-6
pubmed: 19498109
Biochemistry. 2001 Nov 6;40(44):13274-80
pubmed: 11683637
Trends Biochem Sci. 2007 Jan;32(1):37-43
pubmed: 17141506
Genes Dev. 2004 Dec 1;18(23):2905-15
pubmed: 15545623
Development. 2005 May;132(9):2125-34
pubmed: 15800001
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Cell Death Differ. 2009 Oct;16(10):1362-71
pubmed: 19557011
Dev Cell. 2018 May 21;45(4):450-464.e3
pubmed: 29787709
Mol Cell Oncol. 2015 Apr 08;2(4):e975093
pubmed: 27308513
Cell Res. 2009 Mar;19(3):392-4
pubmed: 19223855
Nat Rev Mol Cell Biol. 2008 May;9(5):378-90
pubmed: 18414491
Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14
pubmed: 20823910
Cell Death Differ. 2006 Oct;13(10):1697-706
pubmed: 16645642
Elife. 2017 Aug 30;6:
pubmed: 28853394
Cell Death Differ. 2010 Mar;17(3):534-9
pubmed: 19960024
BMC Biol. 2015 Jul 08;13:48
pubmed: 26152191
Dev Cell. 2010 Jun 15;18(6):999-1011
pubmed: 20627081

Auteurs

Mingli Li (M)

School of Biosciences, University of Birmingham, Birmingham, UK.

Shiyao Sun (S)

School of Biosciences, University of Birmingham, Birmingham, UK.

Jessica Priest (J)

School of Biosciences, University of Birmingham, Birmingham, UK.

Xiaolin Bi (X)

College of Basic Medical Sciences, Dalian Medical University, Dalian, China.

Yun Fan (Y)

School of Biosciences, University of Birmingham, Birmingham, UK. y.fan@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH